Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-06 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |